Clinical Trial Update: Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating interferon alfa after chemotherapy and peripheral stem cell transplantation in patients with Stage III or Stage IV multiple my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: University of Tennessee | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED